Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study. | Thromb Haemost | 2023 | 37517407 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives. | Molecules | 2023 | 37513418 | PubTator, text mining | PubMed |
| The Contribution of Vascular Proteoglycans to Atherothrombosis: Clinical Implications. | Int J Mol Sci | 2023 | 37511615 | PubTator, text mining | PubMed |
| Challenges and Future Trends in Atopic Dermatitis. | Int J Mol Sci | 2023 | 37511138 | PubTator, text mining | PubMed |
| Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review. | Cells | 2023 | 37508529 | PubTator, text mining | PubMed |
| The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes. | J Clin Invest | 2023 | 37471144 | PubTator, text mining | PubMed |
| The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets. | Int J Mol Sci | 2023 | 37446251 | PubTator, text mining | PubMed |
| Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications. | Cells | 2023 | 37443746 | PubTator, text mining | PubMed |
| Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation? | Interv Cardiol | 2023 | 37435601 | PubTator, text mining | PubMed |
| Hibernation and hemostasis. | Front Physiol | 2023 | 37435313 | PubTator, text mining | PubMed |
| Urothelial Oxidative Stress and ERK Activation Mediate HMGB1-Induced Bladder Pain. | Cells | 2023 | 37408274 | PubTator, text mining | PubMed |
| First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants. | Platelets | 2023 | 37394920 | PubTator, text mining | PubMed |
| Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer. | Genes Environ | 2023 | 37391844 | PubTator, text mining | PubMed |
| Electroacupuncture Relieves Visceral Hypersensitivity via Balancing PAR2 and PAR4 in the Descending Pain Modulatory System of Goats. | Brain Sci | 2023 | 37371401 | PubTator, text mining | PubMed |
| Advances in Enhancing Hemocompatibility of Hemodialysis Hollow-Fiber Membranes. | Adv Fiber Mater | 2023 | 37361105 | PubTator, text mining | PubMed |
| A scoping review: What are the cellular mechanisms that drive the allergic inflammatory response to fungal allergens in the lung epithelium? | Clin Transl Allergy | 2023 | 37357550 | PubTator, text mining | PubMed |
| Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator? | J Am Heart Assoc | 2023 | 37345795 | PubTator, text mining | PubMed |
| Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production. | Cardiovasc Res | 2023 | 37309666 | PubTator, text mining | PubMed |
| Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon. | Blood Adv | 2023 | 37307200 | PubTator, text mining | PubMed |
| Cooperation of Complement MASP-1 with Other Proinflammatory Factors to Enhance the Activation of Endothelial Cells. | Int J Mol Sci | 2023 | 37298134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=8